DCGI instructs industry to follow defined pathways for application submission of rational FDCs Read more
DCGI issues notice to Serum Institute over AstraZeneca-Oxford COVID-19 vaccine trial suspension Read more
Stempeutics’ allogeneic cell therapy gets DCGI approval, Cipla to market and distribute Stempeucel Read more